MedTrace Logo

Oral Dexamethasone as an Intervention for Postoperative Pain and Nausea Management in Total Knee Arthroplasty

NCT04432259 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2020-06-16

No results posted yet for this study

Summary

This study aims to determine if oral dexamethasone provides clinically significant improvement in postoperative outcomes, specifically nausea and pain scores.

Conditions

  • Arthritis Knee
  • Postoperative Nausea
  • Postoperative Pain

Interventions

DRUG

Dexamethasone

4 mg bid for 4 days

DRUG

Placebo

oral placebo

Sponsors & Collaborators

  • Henry Ford Health System

    lead OTHER

Principal Investigators

  • Jason Davis, M.D. · Henry Ford Health System

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-31
Primary Completion
2022-06-30
Completion
2022-12-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04432259 on ClinicalTrials.gov